<p>Western blots and quantification of hepatic (A) peroxisome proliferator-activated receptor (PPAR) α, (B) PPARγ, (C) fatty acid synthase (FAS), (D) stearoyl-CoA desaturase (SCD) 1, (E) diglyceride acyltransferase (DGAT) 1, and (F) carbohydrate response element binding protein (ChREBP)-1 expression in normal diet (ND), non-treated HFD, Lobe-treated HFD (1 or 5 mg/kg/d), and Lobe-only mice. Densitometry values for each protein are normalized to β-actin or p84. Data are presented as mean ± SEM. *<i>P</i> <0.05 vs. ND-fed mice; †<i>P</i> <0.05 vs. HFD-fed mice.</p
<p>Effect of Rosiglitazone (R), Pioglitazone (P) and Fenofibrate (F) treatment on cardiomyocyte mRNA...
<p>C57BL/6 mice were fed a high-fat diet (HFD) for either 2 months and treated with linagliptin (3 m...
High-fat (HF) diets typically promote diet-induced obesity (DIO) and metabolic dysfunction (i.e., in...
Lobeglitazone (Lobe) is a novel thiazolidinedione antidiabetic drug that reduces insulin resistance ...
<div><p>Lobeglitazone (Lobe) is a novel thiazolidinedione antidiabetic drug that reduces insulin res...
<p>(A) Serum glucose, (B) serum insulin, (C) homeostatic model assessment of insulin resistance (HOM...
<p><b>Partial least squares-discriminant analysis (PLS-DA) scores scatter plots of liver (A and B) a...
<p>Mice were fed Lobe (1 or 5 mg/kg/d) for 9 weeks (n = 8 per group). (A) Body weight, (B) food inta...
Nonalcoholic fatty liver disease (NAFLD) is strongly associated with insulin resistance. The peroxis...
Peroxisome proliferator-activated receptors (PPAR) play an important role in the regulation of lipid...
Pioglitazone, a selective ligand of peroxisome proliferator-activated receptor gamma (PPARγ), is an ...
Pioglitazone, a selective ligand of peroxisome proliferator-activated receptor gamma (PPARγ), is an ...
We evaluated the influence of sex on the pathophysiology of non-alcoholic fatty liver disease (NAFLD...
We evaluated the influence of sex on the pathophysiology of non-alcoholic fatty liver disease (NAFLD...
High-fat (HF) diets typically promote diet-induced obesity (DIO) and metabolic dysfunction (i.e., in...
<p>Effect of Rosiglitazone (R), Pioglitazone (P) and Fenofibrate (F) treatment on cardiomyocyte mRNA...
<p>C57BL/6 mice were fed a high-fat diet (HFD) for either 2 months and treated with linagliptin (3 m...
High-fat (HF) diets typically promote diet-induced obesity (DIO) and metabolic dysfunction (i.e., in...
Lobeglitazone (Lobe) is a novel thiazolidinedione antidiabetic drug that reduces insulin resistance ...
<div><p>Lobeglitazone (Lobe) is a novel thiazolidinedione antidiabetic drug that reduces insulin res...
<p>(A) Serum glucose, (B) serum insulin, (C) homeostatic model assessment of insulin resistance (HOM...
<p><b>Partial least squares-discriminant analysis (PLS-DA) scores scatter plots of liver (A and B) a...
<p>Mice were fed Lobe (1 or 5 mg/kg/d) for 9 weeks (n = 8 per group). (A) Body weight, (B) food inta...
Nonalcoholic fatty liver disease (NAFLD) is strongly associated with insulin resistance. The peroxis...
Peroxisome proliferator-activated receptors (PPAR) play an important role in the regulation of lipid...
Pioglitazone, a selective ligand of peroxisome proliferator-activated receptor gamma (PPARγ), is an ...
Pioglitazone, a selective ligand of peroxisome proliferator-activated receptor gamma (PPARγ), is an ...
We evaluated the influence of sex on the pathophysiology of non-alcoholic fatty liver disease (NAFLD...
We evaluated the influence of sex on the pathophysiology of non-alcoholic fatty liver disease (NAFLD...
High-fat (HF) diets typically promote diet-induced obesity (DIO) and metabolic dysfunction (i.e., in...
<p>Effect of Rosiglitazone (R), Pioglitazone (P) and Fenofibrate (F) treatment on cardiomyocyte mRNA...
<p>C57BL/6 mice were fed a high-fat diet (HFD) for either 2 months and treated with linagliptin (3 m...
High-fat (HF) diets typically promote diet-induced obesity (DIO) and metabolic dysfunction (i.e., in...